Antibiotic fidaxomicin is an RdRp inhibitor as a potential new therapeutic agent against Zika virus
Article in BMC Medicine (July 2020)
The most recent citing publications are shown below. View all 3 publications that cite this research output on Dimensions.
Article in BMC Medicine (July 2020)
Article in Vaccines (March 2020)
Article in Virologica Sinica (September 2019)